Cargando…

Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia

BACKGROUND: Patients infected by SARS-CoV-2 can develop interstitial pneumonia, requiring hospitalisation or mechanical ventilation. Increased levels of inflammatory biomarkers are associated with development of acute respiratory distress syndrome (ARDS). The aim of the present study was to determin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quartuccio, Luca, Fabris, Martina, Sonaglia, Arianna, Peghin, Maddalena, Domenis, Rossana, Cifù, Adriana, Curcio, Francesco, Tascini, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810025/ https://www.ncbi.nlm.nih.gov/pubmed/33493861 http://dx.doi.org/10.1016/j.cyto.2021.155438

Ejemplares similares

Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care
por: Quartuccio, Luca, et al.
Publicado: (2020)

Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells
por: Cifù, A., et al.
Publicado: (2019)

Pro-Inflammatory Microenvironment Modulates the Transfer of Mutated TP53 Mediated by Tumor Exosomes
por: Domenis, Rossana, et al.
Publicado: (2021)

The Influence of a Stressful Microenvironment on Tumor Exosomes: A Focus on the DNA Cargo
por: Domenis, Rossana, et al.
Publicado: (2020)

Circulating exosomes express α(4)β(7) integrin and compete with CD4+ T cells for the binding to Vedolizumab
por: Domenis, Rossana, et al.
Publicado: (2020)

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation
por: Salvatierra, Juan, et al.
Publicado: (2021)

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2021)

Toll-like Receptor-4 Activation Boosts the Immunosuppressive Properties of Tumor Cells-derived Exosomes
por: Domenis, Rossana, et al.
Publicado: (2019)

Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven et al. Joint Bone Spine 2021;88:105258
por: De Marchi, Ginevra, et al.
Publicado: (2022)

Interleukin 6 is a permissive factor for monocytic colony formation by human hematopoietic progenitor cells
Publicado: (1992)

Early experience with anti-interleukin-6 therapy in COVID-19 hyperinflammation
por: Marwah, Vikas, et al.
Publicado: (2021)

Hyperinflammation due to COVID-19 and the Targeted Use of Interleukin-1 Inhibitors
por: Gasparyan, Armen Yuri, et al.
Publicado: (2022)

Brain Endothelial Cells Activate Neuroinflammatory Pathways in Response to Early Cerebral Small Vessel Disease (CSVD) Patients’ Plasma
por: Cifù, Adriana, et al.
Publicado: (2023)

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
por: Cavalli, Giulio, et al.
Publicado: (2021)

Mudskipper interleukin-34 modulates the functions of monocytes/macrophages via the colony-stimulating factor-1 receptor 1
por: Shen, Hai-Yu, et al.
Publicado: (2020)

Co‐production of Interleukin‐1 and Interleukin‐6 in Tumor Cell Lines Elaborating Colony‐stimulating Factors
por: Okuno, Yoshiaki, et al.
Publicado: (1991)

Stimulation of rat hepatocyte fibronectin production by monocyte- conditioned medium is due to interleukin 6
Publicado: (1989)

Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes
Publicado: (1989)

The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia
por: Graziano, Elena, et al.
Publicado: (2022)

Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes
por: Domenis, Rossana, et al.
Publicado: (2018)

The Exposure to Osteoarthritic Synovial Fluid Enhances the Immunomodulatory Profile of Adipose Mesenchymal Stem Cell Secretome
por: Cifù, Adriana, et al.
Publicado: (2020)

Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities
por: Mehta, Puja, et al.
Publicado: (2020)

ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease
por: Janes, Francesco, et al.
Publicado: (2019)

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
por: Della-Torre, Emanuel, et al.
Publicado: (2020)

Osteoprotegerin, interleukin and hepatocyte growth factor for prediction of diabetes and hypertension in the third trimester of pregnancy
por: Huang, Su-Jing, et al.
Publicado: (2020)

Selective induction of interleukin-6 in mouse microglia by granulocyte-macrophage colony-stimulating factor
por: Suzumura, Akio, et al.
Publicado: (1996)

Interleukin-6 and granulocyte colony-stimulating factor as predictors of the prognosis of influenza-associated pneumonia
por: Zhang, Jiaying, et al.
Publicado: (2022)

High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients
por: Fabris, Martina, et al.
Publicado: (2022)

Post-COVID-19 Arthritis and Sacroiliitis: Natural History with Longitudinal Magnetic Resonance Imaging Study in Two Cases and Review of the Literature
por: Colatutto, Donatella, et al.
Publicado: (2021)

Studies on Colony Stimulating Factor Receptor-1 and Ligands Colony Stimulating Factor-1 and Interleukin-34 in Alzheimer's Disease Brains and Human Microglia
por: Walker, Douglas G., et al.
Publicado: (2017)

Transforming Growth Factor β1, in the Presence of Granulocyte/Macrophage Colony-stimulating Factor and Interleukin 4, Induces Differentiation of Human Peripheral Blood Monocytes into Dendritic Langerhans Cells
por: Geissmann, Frederic, et al.
Publicado: (1998)

Cytokines, granulocyte-monocyte colony stimulating factor, interleukin-3 and erythropoietin: Can be a therapeutic option for the stimulation of hematopoietic progenitor cells in trauma-hemorrhagic shock?
por: Kumar, Manoj, et al.
Publicado: (2016)

The effect of inhibition of leukotriene synthesis on the activity of interleukin-8 and granulocyte-macrophage colony-stimulating factor
por: Roberts, P. J., et al.
Publicado: (1993)

Inhibition of human macrophage colony formation by interleukin 4
Publicado: (1989)

Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Osteoarthritis
por: Domenis, Rossana, et al.
Publicado: (2017)

Interleukin-1 beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer.
por: Gallo, O., et al.
Publicado: (1993)

Hyperinflammation in Two Severe Acute Respiratory Syndrome Coronavirus 2-Infected Adolescents Successfully Treated With the Interleukin-1 Inhibitor Anakinra and Glucocorticoids
por: Calò Carducci, Francesca I., et al.
Publicado: (2020)

Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis
por: Takasugi, Koji, et al.
Publicado: (2006)

Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19
por: Peghin, Maddalena, et al.
Publicado: (2021)

Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients
por: Peghin, Maddalena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b37k9oncabi7m0upjh5ft5mb2g